| Absorption kinetics of insulin after subcutaneous administration T Søeborg, CH Rasmussen, E Mosekilde, M Colding-Jørgensen European journal of pharmaceutical sciences 36 (1), 78-90, 2009 | 96 | 2009 |
| Molecular engineering of safe and efficacious oral basal insulin F Hubálek, HHF Refsgaard, S Gram-Nielsen, P Madsen, E Nishimura, ... Nature communications 11 (1), 3746, 2020 | 41 | 2020 |
| Insulin aspart pharmacokinetics: an assessment of its variability and underlying mechanisms CH Rasmussen, RM Røge, Z Ma, M Thomsen, RL Thorisdottir, JW Chen, ... European journal of pharmaceutical sciences 62, 65-75, 2014 | 28 | 2014 |
| Bioavailability and variability of biphasic insulin mixtures T Søeborg, CH Rasmussen, E Mosekilde, M Colding-Jørgensen European journal of pharmaceutical sciences 46 (4), 198-208, 2012 | 28 | 2012 |
| Spatial distribution of soluble insulin in pig subcutaneous tissue: effect of needle length, injection speed and injected volume M Thomsen, CH Rasmussen, HHF Refsgaard, KM Pedersen, RK Kirk, ... European Journal of Pharmaceutical Sciences 79, 96-101, 2015 | 24 | 2015 |
| A comprehensive approach to benefit–risk assessment in drug development SB Sarac, CH Rasmussen, MA Rasmussen, CE Hallgreen, T Søeborg, ... Basic & clinical pharmacology & toxicology 111 (1), 65-72, 2012 | 16 | 2012 |
| Pharmacokinetic/pharmacodynamic modeling of drug interactions at the P2Y12 receptor between selatogrel and oral P2Y12 antagonists A Henrich, CH Claussen, J Dingemanse, A Krause CPT: Pharmacometrics & Systems Pharmacology 10 (7), 735-747, 2021 | 7 | 2021 |
| Absorption kinetics of insulin mixtures after subcutaneous administration CH Rasmussen, T Søeborg, E Mosekilde, M Colding-Jørgensen Biosimulation in Biomedical Research, Health Care and Drug Development, 329-359, 2012 | 7 | 2012 |
| Data‐Driven Assessment of the Association of Polymorphisms in 5‐Fluorouracil Metabolism Genes with Outcome in Adjuvant Treatment of Colorectal Cancer SB Sarac, CH Rasmussen, S Afzal, S Thirstrup, SA Jensen, ... Basic & clinical pharmacology & toxicology 111 (3), 189-197, 2012 | 6 | 2012 |
| PharmTeX: a LaTeX-based open-source platform for automated reporting workflow CH Rasmussen, MK Smith, K Ito, V Sundararajan, MO Magnusson, ... The AAPS Journal 20, 1-11, 2018 | 5 | 2018 |
| Exposure-Response Analysis of Cannabidiol for the Treatment of Lennox-Gastaut Syndrome G Morrison, ML Sardu, CH Rasmussen, K Sommerville, C Roberts, ... EPILEPSIA 59, S11-S12, 2018 | 2 | 2018 |
| Exposure-Response Analysis of Cannabidiol (CBD) Oral Solution for the Treatment of Lennox–Gastaut Syndrome (P1. 271) G Morrison, ML Sardu, CH Rasmussen, K Sommerville, C Roberts, ... Neurology 90 (15 Supplement), 2018 | 1 | 2018 |
| 13 Biosimulation of Peptides and Proteins T Søeborg, CH Rasmussen, E Mosekilde, M Colding-Jørgensen Pharmaceutical Formulation Development of Peptides and Proteins, 323, 2012 | 1 | 2012 |
| PharmTeX: a LaTeX-based open-source platform for automated reporting workflow CH Rasmussen, T Nicholas JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS 44, S78-S78, 2017 | | 2017 |
| Population Approach Group Europe Population Approach Group Europe CH Claussen | | |
| Report Title: PharmTeX User Guide Date Issued: 15 JAN 2019 Version: 1.6 CH Rasmussen | | |
| Report Title: PharmTeX User Guide Date Issued: 28 MAR 2019 Version: 1.7 CH Rasmussen | | |
| Report Title: PharmTeX User Guide Date Issued: 02 OCT 2018 Version: 1.5 CH Rasmussen | | |
| 2024 Rome, Italy CH Rasmussen | | |
| Pharmacokinetics of concentrated insulin mixtures: a biosimulation approach Christian Hove Rasmussen Novo Nordisk A/S CH Claussen | | |
